Michael Campbell
Vorstandsvorsitzender bei COMERA LIFE SCIENCES HOLDINGS, INC.
Vermögen: 805 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Michael Campbell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Campbell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Specialized Health Products International, Inc.
 Specialized Health Products International, Inc. Medical SpecialtiesHealth Technology Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT. | Medical Specialties | Director/Board Member | |
| AGENUS INC. | Biotechnology | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| HURON CONSULTING GROUP INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KURA ONCOLOGY, INC. | Biotechnology | Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree | |
BBK Ltd.
 BBK Ltd. Miscellaneous Commercial ServicesCommercial Services BBK Ltd. provides finance, strategy, operations and general managements consultancy services. It provides finance, strategy, operations and general management consultancy services that monitor the growth, profits and stability of its clients. The company's clients include corporations, mid-sized companies, financial institutions, law firms and private equity firms. BBK was founded by B.N. Bahadur in 1977 and is headquartered in Southfield, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| Lycoming College | College/University | Undergraduate Degree | |
| Massachusetts College of Pharmacy & Health Science | College/University | Undergraduate Degree | |
Berenson & Co, Inc.
 Berenson & Co, Inc. Investment Banks/BrokersFinance Berenson & Co, Inc. is a merchant bank that was founded in 1990. The private company is based in New York, NY and has subsidiaries in the United States. The company has two principal lines of business which are investment banking and private equity investing. The company was founded by Robb Eric Turner and Jeffrey L. Berenson. Jeffrey L. Berenson has been the CEO since incorporation. | Investment Banks/Brokers | Corporate Officer/Principal | |
| University of Arizona | College/University | Undergraduate Degree | |
| The University of Colorado | College/University | Doctorate Degree | |
| University of Phoenix | College/University | Masters Business Admin | |
| Wesleyan University | College/University | Undergraduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | Chief Operating Officer | |
Polymer Ventures, Inc.
 Polymer Ventures, Inc. Wholesale DistributorsDistribution Services Polymer Ventures, Inc. engages in the provision of specialty chemicals. Its products include pulp and paper, automotive paint booth, industrial wastewater, mineral processing, cooling water, personal care, textile, and electronics. It also offers custom product development, technical support, and customer satisfaction services. The company was founded in 1988 and is headquartered in Charleston, SC. | Wholesale Distributors | Chief Tech/Sci/R&D Officer | |
VMR Electronics LLC
 VMR Electronics LLC Electrical ProductsProducer Manufacturing VMR Electronics LLC designs and manufactures cable assembly products. The company was founded by Mark and Vanessa Kelly in 2001 and is headquartered in Binghamton, NY. | Electrical Products | Corporate Officer/Principal | |
| Bryant University | College/University | Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree | |
| Paribas Properties, Inc. | Founder | ||
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
Crop Enhancement LLC
 Crop Enhancement LLC Chemicals: AgriculturalProcess Industries Crop Enhancement LLC develops green formulation technologies for improving agricultural production. It offers three environmental products platform: CropCoat Produce Protection, Agrochemical Encapsulatio, and Particle Stabilization. The company was founded by David Soane and Zach Jonasson in 2011 and is headquartered in Cambridge, MA. | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
Upstate New York Power Producers, Inc.
 Upstate New York Power Producers, Inc. Electric UtilitiesUtilities Upstate New York Power Producers, Inc. owns and operates coal-fired power plants. The company is headquartered in Lansing, NY. | Electric Utilities | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
| Tulane University School of Medicine | College/University | Doctorate Degree | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Biotechnology | Corporate Officer/Principal | |
Sigma-tau Healthscience USA, Inc.
 Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Essetifin SpA, Sigma-tau Healthscience USA, Inc. provides health solutions that focus on mitochondrial functioning. Sigma-tau Healthscience USA is based in Gaithersburg, MD. Mitochondria are the energy factories of cells, and healthy mitochondria contribute to various health benefits. Sigma-tau Healthscience USA's Mitocarn™ provides healthy mitochondrial functioning in three ways: by providing energy to the body, supporting mitochondrial function, and strengthening core cellular functions. The company offers four targeted L-carnitine solutions, including Mitocarn™ Heart, which provides extra energy to heart cells during the metabolic process and helps increase blood flow to the heart and muscles. | Pharmaceuticals: Major | Chief Operating Officer | |
CutisPharma Holdings, Inc.
 CutisPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology CutisPharma Holdings, Inc. operates in the pharmaceuticals industry. The company is headquartered in Raleigh, NC. | Pharmaceuticals: Major | Director/Board Member | |
Homer City Holdings, LLC
 Homer City Holdings, LLC Financial ConglomeratesFinance Homer City Holdings, LLC is an investment holding private company. The company is based in Dauphin, PA. William A. Wexler has been the CEO of the company since 2017. | Financial Conglomerates | Chief Executive Officer | |
Azurity Pharmaceuticals, Inc.
 Azurity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azurity Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on the needs of patients, especially children and the elderly, requiring customized, user-friendly drug formulations. The firm?s products include Epaned, Qbrelis, Xatmep and FIRVANQ oral solutions. The company was founded in 1998 and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Sobi, Inc. | Chief Tech/Sci/R&D Officer | ||
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chairman Chief Operating Officer Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| Wexler Consulting LLC | Corporate Officer/Principal | ||
| Lyvgen Biopharma Holdings Ltd | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 49 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 4 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 40 |
| Corporate Officer/Principal | 32 |
| Chief Tech/Sci/R&D Officer | 14 |
| Independent Dir/Board Member | 13 |
| Undergraduate Degree | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Michael Campbell
- Unternehmensverbindungen